|
|
|
|
| LEADER |
04357nam a22003135i 4500 |
| 001 |
978-1-59745-197-0 |
| 005 |
20191026192634.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781597451970
|
| 024 |
7 |
|
|a 10.1007/978-1-59745-197-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Opiate Receptors and Antagonists
|b From Bench to Clinic /
|c edited by Reginald Dean, Edward J. Bilsky, S. Stevens Negus.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2009.
|
| 300 |
|
|
|a XXIII, 757 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Contemporary Neuroscience
|
| 505 |
0 |
|
|a Opioid Receptors -- Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance -- Upregulation of Opioid Receptors -- Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders -- Opioid Receptor Antagonist-Mediated Signaling in the Immune System -- Opioid Antagonists: Chemistry and Pharmacology -- The Chemistry and Pharmacology of ?-Opioid Antagonists -- Medicinal Chemistry of Kappa Opioid Receptor Antagonists -- The Chemistry and Pharmacology of Delta Opioid Antagonists -- Novel Opioid Antagonists with Mixed/Dual Selectivity -- Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists -- Methylnaltrexone: A Peripherally Acting Opioid Antagonist -- Substance Abuse -- Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration -- Naltrexone for Initiation and Maintenance of Opiate Abstinence -- Ultra-Low-Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids -- Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of ?-Agonist Opiates -- Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine -- Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence -- Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions -- Alcohol and Ingestive Behaviors -- Opioid Antagonists and Ethanol's Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies -- Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence -- Preclinical Effects of Opioid Antagonists on Feeding and Appetite -- CNS Opiate Systems and Eating Disorders -- Behavioral Disorders -- Potential Utility of Kappa Ligands in the Treatment of Mood Disorders -- Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania -- Efficacy of Opioid Antagonists in Attentuating Self-Injurious Behavior -- Pharmacotherapeutic Effects of Opioid Antagonists in Alcohol-Abusing Patients with Schizophrenia -- Medical Indications -- Current Issues in the Use of Opioid Antagonists (Naltrexone for Opiate Abuse: A Re-Educational Tool as Well as an Effective Drug) -- Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose -- Kappa-Opioid Antagonists as Pruritogenic Agents -- Clinical Effect of Opioid Antagonists on Clinical Pruritus -- Effects of Opioid Antagonists on l-DOPA-Induced Dyskinesia in Parkinson's Disease -- Endocrine Effects of Opioid Antagonists -- Opioid Antagonists in Traumatic Shock: Animal and Human Studies -- The Efficacy of Opioid Antagonists Against Heatstroke-Induced Ischemia and Injury in Rats -- A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasms -- Nonclinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence -- The Development of Sustained-Release Naltrexone and Clinical Use in Treating Opiate Dependence -- The Development of ProNeura Technology for the Treatment of Addictions -- Development of Opioid Transdermal Delivery Systems -- Intranasal Naloxone for Treatment of Opioid Overdose.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
|
|a Dean, Reginald.
|e editor.
|
| 700 |
1 |
|
|a Bilsky, Edward J.
|e editor.
|
| 700 |
1 |
|
|a Negus, S. Stevens.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-59745-197-0
|